EAN consensus statement for management of patients with neurological diseases during the COVID-19 pandemic

T J Von Oertzen, A Macerollo, M A Leone, E Beghi, M Crean, S Oztuk, C. Bassetti, A Twardzik, D Bereczki, G Di Liberto, R Helbok, C Oreja-Guevara (+15 others)
2020
and purpose: The recent SARS-CoV-2 pandemic has posed multiple challenges to the practice of clinical neurology including recognition of emerging neurological complications and management of coexistent neurological diseases. In a fast-evolving pandemic, evidence-based studies are lacking in many areas. This paper presents European Academy of Neurology (EAN) expert consensus statements to guide neurologists caring for patients with COVID-19. Methods: A refined Delphi methodology was applied. In
more » ... ound 1, statements were provided by EAN scientific panels (SPs). In round 2, these statements were circulated to SP members not involved in writing them, asking for agreement/disagreement. Items with agreement >70% were retained for round 3, in which SP co-chairs rated importance on a five-point Likert scale. Results were graded by importance and reported as consensus statements. Results: In round one, 70 statements were provided by 23 SPs. In round two, 259/1061 SP member responses were received. Fifty-nine statements obtained >70% agreement and were retained. In round three, responses were received from 55 co-chairs of 29 SPs. Whilst general recommendations related to prevention of COVID-19 transmission had high levels of Correspondence: T. J.
doi:10.7892/boris.147446 fatcat:sfbpogia35cgljiidgj7vlr74m